Catalys Pacific

What is Catalys Pacific?

Catalys Pacific is a venture capital firm that takes a strategic transpacific partnership approach to create innovation for patients worldwide.

They operate with a mission to develop novel therapies, with a particular focus on uncharted areas in the healthcare and biotechnology spaces.

They specialize in early-stage investments, aiming to generate attractive risk-adjusted returns for their investors by leveraging their expansive global network and establishing new biotech companies. Catalys Pacific has a strong local presence in both Japan and the United States, providing them with unique access to differentiated sourcing opportunities for investment and company creation.

A prominent element of their strategy involves catalyzing partnerships across the Pacific to maximize therapeutic impact for patients by incorporating insights and perspectives from both sides.

Their website highlights several 'Featured Creations,' including companies like Mineralys Therapeutics, which recently completed enrollment in a Phase 2 trial, Renalys and Pathalys, which focus on novel therapy access and new paths for patients with chronic kidney disease respectively.

The firm champions the power of these transpacific partnerships in driving their investment and company-building strategy. They express pride in their team's ability to utilize a profound global network and robust presence in Japan to progress their mission of improving patient lives. The team is dedicated to enacting their charter, which encompasses their core values and operational guiding principles for impacting patient healthcare positively through innovative biomedical advancements.